|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Oral contraceptives, methionine and endothelial lesion. |
| Hladovec J; Koutsky J; Prerovsky I; Dvorak V; Novotny A |
| Estrogen (mestranol), 1 mcg/kg administered for 1 week decreased the tolerance of rats for methionine, and women |
| aged 20-30 years were prescribed oral contraceptives (OCs) after passing the methionine tolerance tests. The OCs |
| prescribed for women were 0.25 and 1 mg cholersuperlutin combined with 0.08 mg mestranol. In 1 group this OC |
| was combined with pyridoxine 120 mg daily in capsules. The study in rats showed oral administration of methionine |
| 50 mg/kg to have no effect on endothelaemia counts. Tolerance for the same dose of methionine markedly |
| decreased in animals treated for 1 week with with an estrogen preparation of mestranol 1 mcg/kg orally. The effect of |
| estrogen treatment on methionine tolerance was completely prevented by simultaneous daily administration of |
| pyridoxine 10 mg/kg. In women the results were expressed in terms of endothelaemia counts before and after the |
| period of contraceptive treatment. In another group of women the OC was administered together with pyridoxine 120 |
| mg daily for the same time period and no significant change in methionine tolerance was observed. The decreased |
| tolerance in women was prevented by administration of OCs in combination with pyridoxine. (PubHealth.info |
| Document ID: CONT5T 2076-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Oral contraceptives, methionine and endothelial lesion.", |
| is(are) Hladovec J; Koutsky J; Prerovsky I; Dvorak V; Novotny A. The source of this article is "Vasa. |
| 1983;12(2):117-20.". This article was published in 1983 in English language(s). (PubHealth.info® Document ID: |
| CONT5T 2076-06. All rights reserved with PubHealth.info) PIN: 22076 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |